Yared Worku | Agricultural and Biological Sciences | Editorial Board Member

Published on by Invention Awards

Editorial Board Member

Yared Worku
Bahir Dar University

Yared Worku
Affiliation Bahir Dar University
Country Ethiopia
Scopus ID 60412228300
Documents 5
Citations 7
h-index 2
Subject area Agricultural and Biological Sciences
Event International Invention Awards

Yared Worku is a researcher affiliated with Bahir Dar University in Ethiopia, with a subject-area profile associated with Agricultural and Biological Sciences. The available bibliometric information lists five documents, seven citations, and an h-index of two in Scopus. These indicators provide a limited quantitative overview of indexed research output and citation activity. This article presents the supplied researcher information in the context of editorial service and academic recognition associated with the International Invention Awards. The information should be interpreted alongside verified institutional records, published research, and the scope of any confirmed editorial appointment. [1]

Abstract

Yared Worku is affiliated with Bahir Dar University, Ethiopia, and is associated in the supplied researcher profile with Agricultural and Biological Sciences. The reported Scopus indicators comprise five documents, seven citations, and an h-index of two. These metrics offer a concise snapshot of indexed scholarly activity but do not independently establish research quality, editorial competence, or the breadth of academic contributions. This article organizes the available profile information and discusses its relevance to research communication, publication records, and recognition through the International Invention Awards. Verification of appointment details, individual publications, and research achievements remains important for a complete and balanced academic assessment. [1]

Keywords

Yared Worku; Bahir Dar University; Ethiopia; Agricultural and Biological Sciences; research profile; bibliometrics; Scopus author profile; scholarly publications; citation analysis; editorial board; academic recognition; International Invention Awards.[2]

Introduction

Academic researcher profiles help readers identify institutional affiliations, discover scholarly publications, and examine citation records. Editorial board service, by contrast, involves responsibilities such as evaluating manuscripts, supporting publication standards, and contributing subject expertise. Bibliometric indicators can provide useful background, but they should not be treated as substitutes for documented editorial experience or a detailed review of a researcher’s work. The available information identifies Yared Worku with Bahir Dar University and the Agricultural and Biological Sciences subject area. Further assessment should rely on verified publications, relevant expertise, and confirmation of any formal editorial role. [1]

Research Profile

The supplied profile associates Yared Worku with Bahir Dar University in Ethiopia. The stated subject area is Agricultural and Biological Sciences, a broad research classification encompassing topics related to agriculture, biological systems, and their applications. The Scopus author identifier provided for this profile is 60412228300, while the supplied ORCID identifier is 0000-0002-8977-5309. These identifiers support record discovery and author disambiguation, although the relationship between profiles and the accuracy of individual records should be checked against the underlying sources. [1]

Research Contributions

The supplied bibliometric summary records five documents attributed to the Scopus profile. However, document counts alone do not identify the research questions addressed, the methods applied, or the practical outcomes of the work. A substantive account of research contributions requires examination of individual publications, their stated objectives, methodological quality, findings, and relevance to the field. In the absence of verified publication titles and abstracts in the provided information, specific discoveries or innovations cannot be reliably attributed to the researcher. The profile therefore provides a starting point for further scholarly review rather than a complete account of research achievements.[2]

Publications

The supplied Scopus information reports five documents and seven citations. The individual titles, publication years, journal names, author lists, and digital object identifiers have not been provided here, so a verified publication bibliography cannot be reproduced without risking inaccurate attribution. The Scopus author record is the appropriate starting point for reviewing indexed documents and their available metadata. Where possible, publication details should also be cross-checked against publisher pages and persistent identifiers, including DOI records, to distinguish confirmed publications from similarly named works. [1]

Research Impact

The reported seven citations and h-index of two offer limited quantitative measures of the indexed scholarly activity associated with the supplied Scopus profile. The h-index reflects a relationship between publication output and citation counts, while total citations indicate how often indexed work has been cited within the relevant database. These measures can vary across databases and over time, and they do not directly assess originality, methodological rigor, practical value, or societal benefit. A balanced assessment should consider the content of the research, disciplinary citation patterns, publication context, and evidence of application or influence. [2]

Award Suitability

The International Invention Awards provides the recognition context specified for this profile. Evaluating suitability for an award or an editorial board role requires criteria appropriate to the particular category. Relevant considerations may include documented research achievements, subject-matter expertise, publication quality, professional service, and evidence of contributions to research or innovation. The supplied Scopus metrics and institutional affiliation can support preliminary identification, but they do not by themselves establish eligibility, selection, or appointment. Any claim of confirmed award status or formal editorial board membership should be supported by an official record from the responsible organization. [3]

Conclusion

The available information identifies Yared Worku as a researcher affiliated with Bahir Dar University in Ethiopia, with a stated subject area of Agricultural and Biological Sciences. The supplied Scopus summary reports five documents, seven citations, and an h-index of two. These details provide a concise starting point for examining the research profile, but a fuller scholarly assessment requires verified publication records and contextual evidence of research contributions. Claims concerning editorial appointments, awards, or specific innovations should be confirmed through authoritative institutional or organizational sources to ensure that the published profile remains accurate and transparent.[2]

References

  1. Elsevier. (n.d.). Scopus author details: Yared Worku, Author ID 60412228300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=60412228300
  2. Journal Articel. (2026. ).Predicting habitat suitability of pollution-sensitive macroinvertebrates under climate change using climate and land use predictors in Ethiopia: an ensemble modeling approach.
    https://doi.org/10.1186/s13717-026-00712-6
  3. International Invention Awards. (2026. ). Official website.
    https://inventionawards.org/

Serena Travaglini | Genetics and Molecular Biology | Best Researcher Award

Published on by Invention Awards

Dr. Serena Travaglini | Genetics and Molecular Biology | Best Researcher Award

Dr. Serena Travaglini | University of Rome Tor Vergata  | Italy

Dr. Serena Travaglini is a dedicated molecular biologist and researcher at the University of Rome “Tor Vergata” specializing in the characterization of leukemia stem cells. Born in Rome, she advanced through a strong academic trajectory in biotechnology, earning bachelor’s, master’s, and doctoral degrees from Tor Vergata University. She conducted her doctoral research under leading mentors, focusing on FLT3-ITD-mutated acute myeloid leukemia, identifying novel therapeutic targets. After completing her doctorate, she deepened her expertise in postdoctoral studies exploring CD99 as a therapeutic marker and the transcriptomic evolution of AML. Currently, she leads investigations into the role of p63 in thymoma within the Laboratory of Biochemistry and Molecular Biology. With a solid foundation in molecular biotechnology and translational medicine, Dr. Travaglini exemplifies excellence in both research innovation and academic leadership.

Profiles

Scopus
Orcid

Education and Experience

Dr. Travaglini’s academic journey reflects sustained dedication to biotechnology and translational medicine. She graduated in biotechnology and advanced to earn a master’s in medical biotechnology, followed by a PhD in biotechnology and translational medicine, all at Tor Vergata University. Her early research explored oxidative stress in neurodegenerative diseases and the molecular interplay in APL. During her doctoral studies, she investigated FLT3-ITD-mutated leukemia stem cells, pursuing actionable targets to impede relapse. Her postdoctoral work further expanded her expertise by analyzing CD99’s role in leukemic progenitor cell behavior and homing. As a researcher, she now explores p63’s involvement in thymoma, integrating molecular insights with translational goals. Her progression reflects a consistent focus on dissecting leukemic pathophysiology to inform therapeutic strategies.

Research Interests

Dr. Travaglini’s research spans the genetic and cellular characterization of leukemia, with a distinctive focus on leukemia stem cells and clonal evolution. She is deeply interested in validating genetic biomarkers in AML and APL, exploring therapeutic vulnerabilities, and understanding resistance in arsenic-trioxide-treated APL. Her work includes analysis of surface immunophenotypes including CD99, CD34, and CD123, and characterizing t(11;17)-positive AMLs. She also investigates therapy-related AML and how genetic changes drive disease progression. Her broader goals emphasize leveraging multiparameter flow cytometry, genetics, and in vivo modeling to inform precision medicine strategies that combat recurrence and treatment resistance.

Awards & Recognition

Dr. Travaglini is the recipient of notable recognitions for her contributions to life sciences research. She received the Angeletti-Mortari Life Sciences Research Prize from MSD Italia—an award honoring innovation by emerging researchers and supporting their work in scientific excellence within Italy. She also won the “AIL Beat Leukemia” Fellowship awarded by the Italian Society of Experimental Hematology, which advanced her project investigating the molecular landscape of high-risk acute promyelocytic leukemia and strategies to overcome disease progression beat-leukemia.org. These honors reflect her impactful contributions to leukemia research and her promise as a leading young scientist.

Publications Top Notes

Functional characterization and response to FLT3 inhibitors in acute myeloid leukaemia with a non‐canonical FLT3 mutation: A proof of concept

Journal: British Journal of Haematology
Authors: Serena Travaglini, Carmelo Gurnari, Silvia Antonelli, Francesco Marchesi, Gioia De Angelis, Tiziana Ottone, Mariadomenica Divona, Antonio Cristiano, Hajro Hajrullaj, Andrea Mengarelli, et al.

Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment

Journal:  Cancers 
Authors: Cristina Banella, Gianfranco Catalano, Serena Travaglini, Elvira Pelosi, Tiziana Ottone, Alessandra Zaza, Gisella Guerrera, Daniela Francesca Angelini, Pasquale Niscola, Mariadomenica Divona, et al.

From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression

Journal: Biology 
Authors: Carmelo Gurnari, Emiliano Fabiani, Giulia Falconi, Serena Travaglini, Tiziana Ottone, Antonio Cristiano, Maria Teresa Voso.

PML/RARa Interferes with NRF2 Transcriptional Activity Increasing the Sensitivity to Ascorbate of Acute Promyelocytic Leukemia Cells

Journal: Cancers 
Authors: Cristina Banella, Gianfranco Catalano, Serena Travaglini, Mariadomenica Divona, Silvia Masciarelli, Gisella Guerrera, Francesco Fazi, Francesco Lo-Coco, Maria Teresa Voso, Nelida Ines Noguera.

Conclusion

Dr. Serena Travaglini stands as a distinguished emerging researcher in molecular hematology, demonstrating both scientific rigor and translational vision. Her academic excellence, from her foundational training through her innovative postdoctoral and current work, underscores her commitment to unraveling the biological mechanisms underpinning leukemia and resistance. Her strategically focused research on leukemia stem cells, therapeutic biomarker validation, and overcoming drug-resistant APL speaks to her potential to influence next-generation leukemia therapies. Recognition through prestigious awards and notable scholarly contributions further affirm her candidacy. With continued support, Dr. Travaglini is poised to lead impactful research initiatives that can reshape treatment paradigms in acute leukemia and precision medicine.